Upstream Bio, Inc.
UPB
$8.56
-$0.09-1.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -38.62M | -28.63M |
| Total Depreciation and Amortization | -- | -- | -- | 57.00K | 58.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -9.14M | -11.92M |
| Change in Net Operating Assets | -- | -- | -- | -3.60M | -6.50M |
| Cash from Operations | -- | -- | -- | -51.29M | -46.99M |
| Capital Expenditure | -- | -- | -- | 0.00 | -72.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -30.54M | -23.99M |
| Cash from Investing | -- | -- | -- | -30.54M | -24.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 9.54M | 9.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 74.96M | 64.81M |
| Repurchase of Preferred Stock | -- | -- | -- | -183.00K | -183.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -66.50K | -- |
| Cash from Financing | -- | -- | -- | 84.26M | 74.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 2.42M | 3.07M |